×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: Targeted Protein Degradation for Neurodegenerative Diseases
therapeutic
924 words
KG: Targeted Protein Degradation for Neurodegenerative Diseases
2026-03-22
kind:therapeutic
section:therapeutics
state:published
Contents
Targeted Protein Degradation for Neurodegenerative Diseases
💊
Therapeutic Info
Name
Targeted Protein Degradation for Neurodegenerative Diseases
Summary
Page for Targeted Protein Degradation for Neurodegenerative Diseases
Knowledge Graph
Related Hypotheses (28)
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Lysosomal Calcium Channel Modulation Therapy
Score: 0.49
Lysosomal Enzyme Trafficking Correction
Score: 0.49
Chaperone-Mediated APOE4 Refolding Enhancement
Score: 0.48
Lysosomal Membrane Repair Enhancement
Score: 0.45
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45
Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.43
Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles
Score: 0.53
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.51
Heat Shock Protein 70 Disaggregase Amplification
Score: 0.51
Proteostasis Enhancement via APOE Chaperone Targeting
Score: 0.50
Orexin-Microglia Modulation Therapy
Score: 0.49
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46
Hypocretin-Neurogenesis Coupling Therapy
Score: 0.45
APOE Isoform Conversion Therapy
Score: 0.44
Serine/Arginine-Rich Protein Kinase Modulation
Score: 0.42
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41
Targeted Butyrate Supplementation for Microglial Phenotype M
Score: 0.56
Restoring Neuroprotective Tryptophan Metabolism via Targeted
Score: 0.45
Microglia-Derived Extracellular Vesicle Engineering for Targ
Score: 0.37
Show 23 more
Related Analyses (17)
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed
Show 12 more
Related Experiments (4)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
s:** - Biochemical binding assays measuring PROTAC selectivi
falsification · proposed · Score: 0.40
Multi-omics analysis of myricanol effects on gene expression
exploratory · proposed · Score: 0.88
LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne
validation · proposed · Score: 0.40
See Also (15)
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 7 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 7 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 7 hypotheses
VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 7 hypotheses
Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 7 hypotheses
Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 7 hypotheses
ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 7 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 7 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 7 hypotheses
Therapeutic Targets in Neurodegeneration
mechanism · Pages share 7 hypotheses
Tertiary Lymphoid Organs in Neurodegeneration
mechanism · Pages share 7 hypotheses
T-Cell Dysfunction in Neurodegeneration
mechanism · Pages share 7 hypotheses
Synthetic Lethality and PARP Inhibition in Neurodegener
mechanism · Pages share 7 hypotheses
synaptic-vesicle-cycling-neurodegeneration
mechanism · Pages share 7 hypotheses
SUMOylation in Neurodegeneration
mechanism · Pages share 7 hypotheses
Show 10 more